New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AVIR on Nasdaq ・ Market Cap: Small
New Purchase Insider
CEO Sales
Top Executive Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 2 / 10 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 1 / 8 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 50,000 / 563,073 25,000 / 56,307 |
| VALUE PURCHASED/SOLD Transaction Average | $164,000 / $1,811,794 $82,000 / $181,179 |
| PURCHASE RANGE | $82,000 - $82,000 |
| SALE RANGE | $4,024 - $1,024,877.1 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
1 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
100%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
87.56%
DIRECTORS
12.44%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.616 0.295 |
VALUE GINI INDEX Sector Average | 0.658 0.288 |
Atea Pharmaceuticals, Inc. 1Y Trade Transactions